Prevalence of Insulin Receptor Substrate-1 Gene (G972R) Polymorphism, Insulin Resistance, and Determination of β-Cell Function among Overweight and Obese Persons with Type 2 Diabetes Mellitus

Thae Nu  Htwe; Ohnmar Myint Thein; Saw Wut Hmone; Myat Thandar

doi:10.15605/jafes.036.01.03

Authors

Thae Nu Htwe University of Medicine 2, Yangon, The Republic of the Union of Myanmar https://orcid.org/0000-0003-1049-0704
Ohnmar Myint Thein University of Medicine 2, Yangon, The Republic of the Union of Myanmar
Saw Wut Hmone University of Medicine 1, Yangon, The Republic of the Union of Myanmar
Myat Thandar University of Nursing, Yangon, The Republic of the Union of Myanmar

DOI:

https://doi.org/10.15605/jafes.036.01.03

Keywords:

IRS-1, insulin resistance, β-cell function, lipid profile

Abstract

*Visual Abstract prepared by Dr. Francis Xavier Mislang

Background. Type 2 diabetes mellitus (T2DM) is the most common metabolic disorder and its pathogenesis is characterized by a combination of peripheral insulin resistance and impaired insulin secretory capacity of pancreatic β-cell. Genetic predisposition interacts with environmental factors including diet, physical activity, and age leading to the development of diabetes.

Objective. To determine the proportion of overweight and obese persons with type 2 diabetes and to compare the fasting blood sugar, fasting serum insulin, insulin resistance and β-cell function in G972R carrier and non-carrier overweight and obese persons with type 2 diabetes.

Methodology. One hundred overweight and obese patients with T2DM were recruited from persons with diabetes attending the Diabetes Outpatient Department of Yangon General Hospital. History taking and physical examination were done and blood samples were collected. Plasma glucose level was determined by the glucose oxidase method and fasting serum insulin was measured by enzyme-linked immunoassay (ELISA) kit method. Polymerase chain reaction and Restriction Fragment Length Polymorphism were done for genetic polymorphism.

Results. Among 100 overweight and obese subjects with T2DM, 81 patients were of homozygous (G/G) genotype, 18 patients were of heterozygous (G/A) and only one patient of homozygous (A/A) genotype. There was no statistically significant difference in the proportion of genotypes between overweight and obese subjects with T2DM.

There was no significant difference in fasting blood sugar (FBS), fasting serum insulin, HOMA-IR, β-cell function, lipid parameters between IRS-1 (G972R) carriers and non-carriers. There is significant negative correlation between insulin resistance and TG level (r2=0.0529, p=0.01).

Conclusion. It was concluded that IRS-1 G972R polymorphism was not important in insulin resistance, β-cell function and lipid parameters in overweight and obese T2DM. There could be a number of candidate genes in the pathophysiology of diabetes mellitus, genetic sequencing of IRS-1 and other genes in the insulin signaling pathway, and finding out the alteration in their genetic patterns would provide clues for the association of the site-specific polymorphisms of these genes with insulin resistance in T2DM.

Downloads

Download data is not yet available.

Author Biographies

Thae Nu Htwe, University of Medicine 2, Yangon, The Republic of the Union of Myanmar

Professor, Department of Physiology

Ohnmar Myint Thein, University of Medicine 2, Yangon, The Republic of the Union of Myanmar

Professor, Department of Physiology

Saw Wut Hmone, University of Medicine 1, Yangon, The Republic of the Union of Myanmar

Professor, Department of Pathology

Myat Thandar, University of Nursing, Yangon, The Republic of the Union of Myanmar

Rector

References

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53. https://pubmed.ncbi.nlm.nih.gov/9686693. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.

World Health Organization. Diabetes Fact sheet No. 312, August 2011 Available from http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed October 30, 2011.

World Health Organization. WHO country co-operation strategy 2008-2011 - Myanmar. WHO: India; 2008. https://apps.who.int/iris/bitstream/handle/10665/161143/WHO%20country%20cooperation%20strategy%202008-2011%2C%20Myanmar.pdf?sequence=1&isAllowed=y.

White MF, Kahn CR. The insulin signaling system. J Biol Chem. 1994; 269(1):1–4. https://pubmed.ncbi.nlm.nih.gov/8276779.

Jellema A, Mensink RP, Kromhout D, Saris WHM, Feskens EJM. Metabolic risk markers in an overweight and normal weight population with oversampling of carriers of the IRS-1 972Arg-variant. Atherosclerosis . 2003;171(1):75–81. https://pubmed.ncbi.nlm.nih.gov/14642408. https://doi.org/10.1016/j.atherosclerosis.2003.08.002.

Almind K, Bjørbaek C, Vestergaard H, Hansen T, Eshwald S, Pedersen O. Aminoacid polymorphisms in insulin receptor substrate-1 in non-insulin dependent diabetes mellitus. Lancet. 1993;342(8875):828-32. https://pubmed.ncbi.nlm.nih.gov/8104271. https://doi.org/10.1016/0140-6736(93)92694-o.

Clausen JO, Hansen T, Bjorbaek C, et al. Insulin resistance: Interaction between obesity and a common variant of insulin receptor substrate-1. Lancet 1995;346(8972):397-402. https://pubmed.ncbi.nlm.nih.gov/7623569. https://doi.org/10.1016/s0140-6736(95)92779-4.

Zhang Y, Stratton IM, Warren-Perry MG, Orho M, Groop L, Turner RC. UKPDS 19: Heterogeneity in NIDDM: Separate contributions of IRS-1 and beta3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study. Diabetologia. 1996;39(12):1505-11. https://pubmed.ncbi.nlm.nih.gov/8960833. https://doi.org/10.1007/s001250050605.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model ascessment: Insulin resistance and β - cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28(7):412-9. https://pubmed.ncbi.nlm.nih.gov/3899825. https://doi.org/10.1007/BF00280883.

Bodhini D, Venkatesan R, Viswanathan M. Association study of IRS-1 gene polymorphisms with type 2 diabetes in south Indians. Diabetes Technol Thera. 2011;13(7):767-72. https://pubmed.ncbi.nlm.nih.gov/21612394. https://doi.org/10.1089/dia.2011.0017.

Hitman GA, Hawrami K, McCarthy MI, et al. Insulin receptor substrate-1 gene mutation in NIDDM; Implications for the study of polygenic disease. Diabetologia. 1995;38(4):481-6. https://pubmed.ncbi.nlm.nih.gov/7796990. https://doi.org/10.1007/BF00410287.

Laakso M, Malkki M, Kekäläinen P, Deeb SS. Insulin receptor substrate-I variants in non-insulin-dependent diabetes. JClin Invest. 1994;94(3):1141-6. https://pubmed.ncbi.nlm.nih.gov/8083355. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC295183. https://doi.org/10.1172/JCI117429.

Mori H, Hashiramoto M, Kishimoto M, Kasuga M. Amino acid polymorphisms of the insulin receptor substrate-1 in Japanese noninsulin- dependent diabetes mellitus. J Clin Endocrinol Metab. 1995;80(9):2822-6. https://pubmed.ncbi.nlm.nih.gov/7673430. https://doi.org/10.1210/jcem.80.9.7673430.

Yamada K, Yuan X, Ishiyama S, et al. Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late–onset NIDDM. Diabetes Care. 1998;21(5):753-6. https://pubmed.ncbi.nlm.nih.gov/9589236. https://doi.org/10.2337/diacare.21.5.753.

Sigal RJ, Doria A, Warram JH, Krolewski AS. Codon 972 polymorphism in the insulin receptor substrate-l gene, obesity, and risk of noninsulin- dependent diabetes mellitus. J Clin Endocrinol Metab. 1996;81(4):1657-9. https://pubmed.ncbi.nlm.nih.gov/8636384. https://doi.org/10.1210/jcem.81.4.8636384.

Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL. Variants of the insulin receptor substrate-1 and fatty acid binding protein - 2 genes and the risk of type - 2 diabetes, obesity, and hyperinsulinemia in African-Americans: The atherosclerosis risk in communities study. Diabetes 1999;48(9):1868-72. https://pubmed.ncbi.nlm.nih.gov/10480621. https://doi.org/10.2337/diabetes.48.9.1868.

Orkunoglu Suer FE, Mergen H, Bolu E, Ozata M. Molecular scanning for mutations in the insulin receptor substrate-1(IRS-1) gene in Turkish with type - 2 diabetes mellitus. Endocr J. 2005;52(5):593-8. https://pubmed.ncbi.nlm.nih.gov/16284438. https://doi.org/10.1507/endocrj.52.593.

Srivastava S, Achyut BR, Prakash J, Agarwal CG, Pant DC, Balraj M. Association of β2-adrenergic receptor and insulin receptor substrate-1 polymorphism with obesity in a Northern Indian population. Indian J Hum Genet. 2008;14(2):48-54. https://pubmed.ncbi.nlm.nih.gov/20300294. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840788. https://doi.org/10.4103/0971-6866.44105.

Ura S, Araki E, Kishikawa H, et al. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: Identification of five novel polymorphisms. Diabetologia. 1996;39(5):600-8. https://pubmed.ncbi.nlm.nih.gov/8739921. https://doi.org/10.1007/BF00403308.

Burguete-Garcia AI, Cruz-Lopez M, Madrid-Marina V, et al. Association of Gly972Arg polymorphism of IRS-1 gene with type - 2 diabetes mellitus in lean participants of a national health survey in Mexico: A candidate gene study. Metabolism. 2010;59(1):38-45. https://pubmed.ncbi.nlm.nih.gov/19716569. https://doi.org/10.1016/j.metabol.2009.07.007.

Chuang LM, Lai CS, Yeh JI, Wu HP, Tai TY, Lin JB No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in Taiwanese population. Diabetes Care 1996; 19(5): 446-9. https://pubmed.ncbi.nlm.nih.gov/8732707. https://doi.org/10.2337/diacare.19.5.446.

Imai Y, Fusco A, Suzuki Y, et al. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1994;79(6):1655-8. https://pubmed.ncbi.nlm.nih.gov/7989470. https://doi.org/10.1210/jcem.79.6.7989470.

Laukkanen O, Pihlajamäki J, Lindström J, et al. Common polymorphisms in the genes regulating the early insulin signalling pathway: Effects on weight change and the conversion from impaired glucose tolerance to type-2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia. 2004;47(5):871-7. https://pubmed.ncbi.nlm.nih.gov/15127203. https://doi.org/10.1007/s00125-004-1395-6.

Benecke H, Topak H, von zur Mühlen A, Schuppert F. A study on the genetics of obesity: Influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate-1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors. Exp Clin Endocrinol Diabetes 2000;108(2): 86-92. https://pubmed.ncbi.nlm.nih.gov/10826514. https://doi.org/10.1055/s-2000-5801.

Samantha P, Venkateswarlu M, Sivaprabodh V. Lipid profile levels in type - 2 diabetes mellitus from the Tribal population of Adilabad in Andhra Pradesh, India. J Clin Diagn Res. 2012;6:590-2.

Ferris HA, Kahn CR. Unraveling the paradox of selective insulin resistance in the Liver: The brain–liver connection. Diabetes. 2016;65(6):1481–3. https://pubmed.ncbi.nlm.nih.gov/27222392. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878421. https://doi.org/10.2337/dbi16-0010.

Zheng T, Gao Y, Tian H. Relationship between blood lipid profiles and pancreatic islet β-cell function in Chinese men and women with normal glucose tolerance: A cross-sectional study. BMC Public Health. 2012;12:634. https://pubmed.ncbi.nlm.nih.gov/22876749. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490814. https://doi.org/10.1186/1471-2458-12-634.

Zheng S, Zhou H, Han T, et al. Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride. BMC Endocr Disord. 2015;15:21. https://pubmed.ncbi.nlm.nih.gov/25924608. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423127. https://doi.org/10.1186/s12902-015-0018-1.

Ma M, Liu H, Yu J, et al. Triglyceride is independently correlated with insulin resistance and islet beta cell function: A study in population with different glucose and lipid metabolism states. Lipids Health Dis. 2020;19(1):121. https://pubmed.ncbi.nlm.nih.gov/32487177. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268278. https://doi.org/10.1186/s12944-020-01303-w.